Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Companyâ€™s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâ€™s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	3.83M 3.35M 3.09M 2.85M 5.36M 369M 5.48M 36.91M 14.52M 181M 14.38M 14.06M 622M	P/E 2023	40.3x	P/E 2024	89x
Enterprise Value	38.02M 33.23M 30.66M 28.26M 53.27M 3.66B 54.45M 366M 144M 1.79B 143M 140M 6.17B	EV / Sales 2023	2.17x	EV / Sales 2024	1.5x
Free-Float	38.37%	Yield 2023 *	-	Yield 2024	-

27/03	Altivera Medical Holdings, LLC acquired Zynex, Inc.	CI
27/03	Zynex, Inc. Secures Term Loan Credit Agreement Finalized	CI
26/03	Zynex, Inc. Emerged from Bankruptcy	CI
21/03	Court confirms Zynex plan of reorganization on March 19, 2026 - SEC filing	RE
19/03	Third Amended Reorganization Plan Approved for Zynex, Inc.	CI
20/02	Zynex Inc says SEC concluded investigation into Zynex, no enforcement action planned	RE
18/02	Zynex Inc resolves federal investigation into business practices	RE
10/02	Notice of Auction Cancellation and Designation of Successful Bidder Filed by Zynex, Inc.	CI
07/02	Third Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
05/02	Zynex, Inc. Announces New In-Network Provider Status with Humana	CI
02/02	Second Amended Joint Disclosure Statement Conditionally Approved and Combined Hearing of Second Amended Disclosure Statement and Reorganization Plan Approved for Zynex, Inc.	CI
01/02	Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
29/01	First Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI

01/08/25	RBC Capital Adjusts Price Target on Zynex to $2 From $3, Maintains Sector Perform Rating	MT
01/08/25	HC Wainwright Downgrades Zynex to Neutral From Buy	MT
01/08/25	Medtech Zynex's Q2 revenue falls more than expected, names new CEO, suspends forecast	RE
15/07/25	RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating	MT
30/04/25	RBC Cuts Price Target on Zynex to $4 From $5, Keeps Sector Perform Rating	MT

28/03	ZYXIQ Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
27/03	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR
27/03	ZYXIQ SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
26/03	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit - ZYXIQ	PR
25/03	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR

27/12/22	Top 50 Small-caps 2023
21/12/22	Top 50 Small-caps 2023
22/10/21	Los valores del Nasdaq con mayor crecimiento
21/10/21	Les actions du Nasdaq avec la plus forte croissance

Zynex Inc. Stock Other OTC

Stocks

US98986M1036

Advanced Medical Equipment & Technology

Valuation: Zynex Inc.

Latest news : Zynex Inc.

Last Transcript: Zynex Inc.

Analysts' recommendations: Zynex Inc.

Press Releases: Zynex Inc.

News in other languages: Zynex Inc.

Quotes and Performance

Managers and Directors: Zynex Inc.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Manager	Title	Age	Since
Steven Dyson CEO	Chief Executive Officer	53	18/08/2025
Vikram Bajaj DFI	Director of Finance/CFO	50	18/08/2025
John Bibb LAW	General Counsel	53	18/08/2025

Director	Title	Age	Since
Vikram Bajaj BRD	Director/Board Member	50	26/03/2026
John Bibb BRD	Director/Board Member	53	26/03/2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZYNEX INC.	+1.63%	+29.33%	-	-	1.69M
THERMO FISHER SCIENTIFIC, INC.	-1.97%	+1.03%	+25.30%	+1.37%	198B
DANAHER CORPORATION	-0.58%	+2.40%	+4.64%	-14.27%	144B
INTUITIVE SURGICAL, INC.	-14.15%	-15.08%	-33.08%	-2.38%	122B
BOSTON SCIENTIFIC CORPORATION	-1.32%	-1.65%	-57.93%	-16.31%	65.44B
EDWARDS LIFESCIENCES CORPORATION	-2.40%	-7.03%	+12.54%	-7.47%	49.36B
SIEMENS HEALTHINEERS AG	-0.11%	+1.53%	-24.62%	-31.81%	44.75B
AGILENT TECHNOLOGIES, INC.	-3.41%	-2.11%	+12.98%	+11.17%	37.13B
WATERS CORPORATION	-2.44%	-1.98%	+24.27%	+36.75%	36.23B
GE HEALTHCARE TECHNOLOGIES INC.	-4.00%	-2.52%	-17.27%	-22.32%	28.69B
Average	-1.39%	-2.30%	-5.91%	-5.03%	80.68B
Weighted average by Cap.	-1.33%	-1.83%	-2.45%	-5.28%

	2023	2024
Net sales	184M 161M 149M 137M 258M 17.75B 264M 1.78B 699M 8.69B 692M 677M 29.93B	192M 168M 155M 143M 269M 18.52B 275M 1.85B 729M 9.07B 722M 707M 31.23B
Net income	9.73M 8.5M 7.85M 7.23M 13.63M 937M 13.94M 93.8M 36.89M 459M 36.55M 35.75M 1.58B	2.99M 2.62M 2.41M 2.23M 4.19M 288M 4.29M 28.86M 11.35M 141M 11.24M 11M 486M
Net Debt	31.59M 27.61M 25.47M 23.48M 44.26M 3.04B 45.24M 304M 120M 1.49B 119M 116M 5.13B	34.19M 29.88M 27.57M 25.42M 47.9M 3.29B 48.97M 330M 130M 1.61B 128M 126M 5.55B